From WSJopinion: A new study published in the Lancet suggests hydroxychloroquine, touted as a Covid treatment by the president, is harmful. A closer look at the data finds glaring errors, writes AllysiaFinley.
President Trump has often mentioned hydroxychloroquine as a potential treatment for Covid-19. Last month he announced that he was taking the antimalaria drug, also known as HCL, as a prophylaxis after two White House staffers tested positive for the virus. Mr. Trump’s critics in the press seem to be on a mission to discredit the therapy. Now a prestigious medical journal may be joining in.
The Lancet published a study on May 22 that purported to find a 30% increased risk of death for hospitalized Covid-19 patients treated...
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
U.S. Sends Two Million Doses Hydroxychloroquine To Brazil Despite Little Evidence It Can Treat CoronavirusThe U.S. has shipped 2 million doses of the antimalarial drug hydroxychloroquine to Brazil, despite little evidence that it can treat the coronavirus
Weiterlesen »
Gilead says remdesivir helped moderate COVID-19 patients improveGilead Sciences Inc said on Monday its antiviral drug remdesivir showed improvement in patients with moderate COVID-19 in a late-stage study.
Weiterlesen »
Gilead trades that made millions on COVID-19 drug news raise eyebrowsWell-timed trades in Gilead Sciences Inc's options ahead of good news on the biopharmaceutical company's COVID-19 drug treatment may draw regulatory scrutiny, experts said.
Weiterlesen »
Russians claim to have an effective treatment for the coronavirus, which hospitals will start using in JuneRussia has approved an anti-influenza drug to treat Covid-19 and will start delivering courses of the drug, Avifavir, to hospitals in June, according to Russia's sovereign wealth fund (RDIF).
Weiterlesen »
Peter Andre clashes with wife Emily over sending their kids back to schoolPeter, 47, profusely disagrees with Emily's opinion of sending their two kids - Amelia, 6, and three-year-old Theo - back to school, resulting in conflict at home
Weiterlesen »
A new batch of data for Gilead Sciences’ remdesivir points to efficacy but it’s no ‘silver bullet’A slice of data from the third clinical trial for Gilead's remdesivir indicates that the experimental therapy is somewhat effective in treating COVID-19 patients -- but is not the silver bullet that had been hoped for. $GIL
Weiterlesen »